Practice Pearls

Targeted Treatment of HR+/HER2-Breast Cancer

June 23rd 2022

Medical experts discuss several topics pertaining to the evolving treatments in HR+/HER2- advanced breast cancer, including unmet needs and the integral role of pharmacists in patient care.

Effective Implementation of Quality Care Programs for Patients With Myeloproliferative Neoplasms

April 16th 2022

Pharmacy specialists discuss quality initiatives for myeloproliferative neoplasms, highlighting the importance of patient-specific, informative care in polycythemia vera, essential thrombocythemia, and myelofibrosis.

The Role of PARP Inhibitors in the Management of Ovarian Cancer

December 17th 2021

Experts in gynecologic oncology review the use of PARP inhibitors in ovarian cancer with a primary focus of these agents as a frontline maintenance strategy.

Understanding the Treatment Landscape for CLL

December 6th 2021

Best Practices for Prophylactic Therapy in Hemophilia A

June 23rd 2021

A panel of experts discuss several topics pertaining to best practices and the challenges in regard to prophylaxis in hemophilia A, including the role of prophylaxis, prophylactic therapy options, outpatient care factors, and economic considerations.

Best Practices for Health-System Pharmacy During COVID-19

March 26th 2021

Madeline Camejo, PharmD, MS, Michael Epshteyn, PharmD, MSM, and Estela Trimino, PharmD, BCPS, provide insights into the best practices implemented within their institutions by health-system pharmacy to address challenges brought on by COVID-19 related to infection control, treatment, and vaccine rollout.

Best Practices for the Management of Neuroendocrine Tumors

March 17th 2021

Best Practices for the Management of Thromboembolism

December 22nd 2020

Best Practices for the Use of Direct Oral Anticoagulants in Obesity

July 28th 2020

Best Practices for the Management of Acute Myeloid Leukemia

April 23rd 2020